UCLA Valencia — Valencia, California

UCLA Valencia is a clinical research site located in Valencia, California, United States.

Crixeo Health Trust Score: 63/100 (FAIR). This profile has not yet been claimed by the site owner.

UCLA Valencia has participated in 2 clinical trials with 1 currently active.

Therapeutic areas: Acinar Cell Adenocarcinoma of the Pancreas, Duct Cell Adenocarcinoma of the Pancreas, Recurrent Pancreatic Cancer.

Sponsors: Translational Oncology Research International, Novartis Pharmaceuticals.

Sponsor Feasibility Report

Trust Score: 63/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for UCLA Valencia?

UCLA Valencia has a Crixeo Trust Score of 63/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has UCLA Valencia conducted?

UCLA Valencia has 2 clinical trials on record, with 1 currently active. Their work covers Acinar Cell Adenocarcinoma of the Pancreas, Duct Cell Adenocarcinoma of the Pancreas, Recurrent Pancreatic Cancer.

Is UCLA Valencia accredited by Crixeo Health?

UCLA Valencia has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about UCLA Valencia?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.